4//SEC Filing
Trigilio Jeffrey 4
Accession 0000899243-23-001157
CIK 0001789972other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 1:48 PM ET
Size
5.3 KB
Accession
0000899243-23-001157
Insider Transaction Report
Form 4
Trigilio Jeffrey
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-30$8.97/sh+201$1,803→ 41,402 total
Footnotes (2)
- [F1]The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of July 1, 2022 through December 30, 2022. This transaction is also exempt under Rule 16b-3(c).
- [F2]In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on December 30, 2022.
Documents
Issuer
Cullinan Oncology, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001838671
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 1:48 PM ET
- Size
- 5.3 KB